NO20021859L - New oligosaccharides, their preparation and pharmaceutical preparations containing the oligosaccharides - Google Patents
New oligosaccharides, their preparation and pharmaceutical preparations containing the oligosaccharidesInfo
- Publication number
- NO20021859L NO20021859L NO20021859A NO20021859A NO20021859L NO 20021859 L NO20021859 L NO 20021859L NO 20021859 A NO20021859 A NO 20021859A NO 20021859 A NO20021859 A NO 20021859A NO 20021859 L NO20021859 L NO 20021859L
- Authority
- NO
- Norway
- Prior art keywords
- oligosaccharides
- preparation
- pharmaceutical preparations
- new
- preparations containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
Abstract
The invention concerns oligosaccharides of formula (I), their mixtures, their diastereomers, methods for preparing them and pharmaceutical compositions containing them.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9913182A FR2800074B1 (en) | 1999-10-22 | 1999-10-22 | NOVEL OLIGOSACCHARIDES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
PCT/FR2000/002897 WO2001029055A2 (en) | 1999-10-22 | 2000-10-18 | Novel oligosaccharides, preparation method and pharmaceutical compositions containing same |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20021859D0 NO20021859D0 (en) | 2002-04-19 |
NO20021859L true NO20021859L (en) | 2002-06-13 |
NO323409B1 NO323409B1 (en) | 2007-04-30 |
Family
ID=9551218
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20021859A NO323409B1 (en) | 1999-10-22 | 2002-04-19 | New oligosaccharides, their preparation, pharmaceutical preparations containing the oligosaccharides and their use. |
Country Status (31)
Country | Link |
---|---|
EP (1) | EP1226148B1 (en) |
JP (1) | JP4733329B2 (en) |
KR (2) | KR100872215B1 (en) |
CN (1) | CN1241932C (en) |
AT (1) | ATE534656T1 (en) |
AU (1) | AU781414B2 (en) |
BR (1) | BR0014939A (en) |
CA (1) | CA2388369C (en) |
CY (1) | CY1112274T1 (en) |
CZ (1) | CZ303255B6 (en) |
DK (1) | DK1226148T3 (en) |
EA (1) | EA004046B1 (en) |
EE (1) | EE05091B1 (en) |
ES (1) | ES2376409T3 (en) |
FR (1) | FR2800074B1 (en) |
HK (1) | HK1050535A1 (en) |
HR (1) | HRP20020330A2 (en) |
HU (1) | HU229385B1 (en) |
IL (2) | IL149154A0 (en) |
ME (1) | MEP9309A (en) |
MX (1) | MXPA02003945A (en) |
NO (1) | NO323409B1 (en) |
NZ (1) | NZ518539A (en) |
PL (1) | PL204623B1 (en) |
PT (1) | PT1226148E (en) |
RS (1) | RS50829B (en) |
SK (1) | SK287459B6 (en) |
TR (1) | TR200201102T2 (en) |
UA (1) | UA72545C2 (en) |
WO (1) | WO2001029055A2 (en) |
ZA (1) | ZA200203102B (en) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4676048B2 (en) * | 2000-07-10 | 2011-04-27 | 生化学工業株式会社 | Demyelinating disease treatment |
WO2002047696A1 (en) * | 2000-12-16 | 2002-06-20 | Aventis Pharma Deutschland Gmbh | Use of low molecular heparin for treating osteoarthritis |
DE10121003A1 (en) | 2001-04-28 | 2002-12-19 | Aventis Pharma Gmbh | Anthranilic acid amides, processes for their preparation, their use as medicaments and pharmaceutical preparations containing them |
WO2003078960A2 (en) | 2002-03-11 | 2003-09-25 | Momenta Pharmaceuticals, Inc. | Analysis of sulfated polysaccharides |
FR2844808B1 (en) * | 2002-09-23 | 2005-02-25 | Aventis Pharma Sa | METHOD OF DETERMINING SPECIFIC GROUPS CONSISTING OF HEPARINS OR HEPARINS OF LOW MOLECULAR WEIGHT |
US20040171819A1 (en) | 2002-10-10 | 2004-09-02 | Aventis Pharma S.A. | Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them |
US7511026B2 (en) * | 2003-03-25 | 2009-03-31 | Seikagaku Corporation | Therapeutic agent for nerve damage |
US7956046B2 (en) * | 2003-07-24 | 2011-06-07 | Aventis Pharma S.A. | Oligosaccharide mixtures derived from heparin, preparation thereof and pharmaceutical compositions containing them |
FR2857971B1 (en) * | 2003-07-24 | 2005-08-26 | Aventis Pharma Sa | MIXTURES OF HEPARIN DERIVED OLIGOSACCHARIDES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
US20050186679A1 (en) * | 2004-02-24 | 2005-08-25 | Christian Viskov | Method for determining specific groups constituting heparins or low molecular weight heparins |
EP1580197A1 (en) * | 2004-03-24 | 2005-09-28 | Aventis Pharma S.A. | Method for quantitatively determining specific groups constituting heparins or low molecular wieght heparins using HPLC |
EP1582531A1 (en) | 2004-03-24 | 2005-10-05 | Aventis Pharma S.A. | Process for oxidizing unfractionated heparins and detecting presence or absence of glycoserine in heparin and heparin products |
DE102005017799A1 (en) * | 2005-04-18 | 2006-10-19 | Abbott Gmbh & Co. Kg | Use of heparin- or heparin derivative to treat illness associated with neurite plasticity or -growth defects, modulates interaction between Nogo receptor and ligands |
US8101733B1 (en) | 2006-06-27 | 2012-01-24 | Momenta Pharmaceuticals, Inc. | Methods of evaluating mixtures of polysaccharides |
US7790466B1 (en) | 2007-01-26 | 2010-09-07 | Momenta Pharmaceuticals, Inc. | Evaluating mixtures of low molecular weight heparins by chain profiles or chain mapping |
US7968082B1 (en) | 2007-01-26 | 2011-06-28 | Momenta Pharmaceuticals, Inc. | Evaluating mixtures of low molecular weight heparins by NMR |
US9139876B1 (en) | 2007-05-03 | 2015-09-22 | Momenta Pharmacueticals, Inc. | Method of analyzing a preparation of a low molecular weight heparin |
EP2256138A1 (en) * | 2009-05-05 | 2010-12-01 | Sanofi-Aventis | Novel acylated 1,6-anhhydro decasaccharide and its use as antithrombotic agent |
FR2949115B1 (en) * | 2009-08-14 | 2012-11-02 | Sanofi Aventis | FGF RECEPTOR ACTIVATOR N-SULFATE OLIGOSACCHARIDES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION |
FR2949114B1 (en) | 2009-08-14 | 2011-08-26 | Sanofi Aventis | FGF RECEPTOR ACTIVATORY N-ACYLATED OCTASACCHARIDES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION |
CN102791742B (en) | 2010-01-19 | 2014-12-24 | 动量制药公司 | Evaluating heparin preparations |
WO2012115952A1 (en) | 2011-02-21 | 2012-08-30 | Momenta Pharmaceuticals, Inc. | Evaluating heparin preparations |
CN102864191A (en) * | 2011-12-16 | 2013-01-09 | 深圳市海普瑞药业股份有限公司 | Heparin disaccharide mixture and preparation method and application thereof |
CN104910217B (en) * | 2015-06-19 | 2018-04-17 | 天津红日药业股份有限公司 | Reference compound for Fondaparinux sodium quality control |
CZ308106B6 (en) * | 2016-06-27 | 2020-01-08 | Contipro A.S. | Unsaturated derivatives of polysaccharides, preparing and using them |
CN110092848A (en) * | 2019-05-14 | 2019-08-06 | 山东辰龙药业有限公司 | A kind of preparation method of Bemiparin sodium |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2519987A1 (en) * | 1982-01-15 | 1983-07-22 | Choay Sa | Uronic acid derivs. - useful as glycoside intermediates or hapten(s) |
AU563351C (en) * | 1982-01-15 | 2003-06-19 | Glaxo Group Limited | Synthesis of oligosaccharides |
FR2764511B1 (en) * | 1997-06-13 | 2000-09-08 | Sanofi Sa | COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF ARTERIAL THROMBOSIS AND USE OF A FACTOR XA INHIBITOR ALONE AND / OR IN COMBINATION WITH A PLAQUET ANTIAGGREGANT |
JP4166851B2 (en) * | 1997-09-29 | 2008-10-15 | 生化学工業株式会社 | Novel inhibitor of ischemia / reperfusion injury |
-
1999
- 1999-10-22 FR FR9913182A patent/FR2800074B1/en not_active Expired - Fee Related
-
2000
- 2000-10-18 CZ CZ20021385A patent/CZ303255B6/en not_active IP Right Cessation
- 2000-10-18 PT PT00969634T patent/PT1226148E/en unknown
- 2000-10-18 PL PL363052A patent/PL204623B1/en not_active IP Right Cessation
- 2000-10-18 NZ NZ518539A patent/NZ518539A/en not_active IP Right Cessation
- 2000-10-18 IL IL14915400A patent/IL149154A0/en active IP Right Grant
- 2000-10-18 BR BR0014939-0A patent/BR0014939A/en active Pending
- 2000-10-18 EE EEP200200208A patent/EE05091B1/en not_active IP Right Cessation
- 2000-10-18 JP JP2001531853A patent/JP4733329B2/en not_active Expired - Fee Related
- 2000-10-18 UA UA2002043067A patent/UA72545C2/en unknown
- 2000-10-18 AU AU79302/00A patent/AU781414B2/en not_active Ceased
- 2000-10-18 MX MXPA02003945A patent/MXPA02003945A/en active IP Right Grant
- 2000-10-18 KR KR1020077018523A patent/KR100872215B1/en not_active IP Right Cessation
- 2000-10-18 SK SK527-2002A patent/SK287459B6/en not_active IP Right Cessation
- 2000-10-18 WO PCT/FR2000/002897 patent/WO2001029055A2/en active IP Right Grant
- 2000-10-18 KR KR1020027005061A patent/KR100778166B1/en not_active IP Right Cessation
- 2000-10-18 TR TR2002/01102T patent/TR200201102T2/en unknown
- 2000-10-18 ES ES00969634T patent/ES2376409T3/en not_active Expired - Lifetime
- 2000-10-18 CN CNB008145318A patent/CN1241932C/en not_active Expired - Fee Related
- 2000-10-18 AT AT00969634T patent/ATE534656T1/en active
- 2000-10-18 CA CA2388369A patent/CA2388369C/en not_active Expired - Fee Related
- 2000-10-18 DK DK00969634.5T patent/DK1226148T3/en active
- 2000-10-18 EP EP00969634A patent/EP1226148B1/en not_active Expired - Lifetime
- 2000-10-18 ME MEP-93/09A patent/MEP9309A/en unknown
- 2000-10-18 EA EA200200479A patent/EA004046B1/en not_active IP Right Cessation
- 2000-10-18 HU HU0203821A patent/HU229385B1/en unknown
- 2000-10-18 RS YUP-298/02A patent/RS50829B/en unknown
-
2002
- 2002-04-15 IL IL149154A patent/IL149154A/en not_active IP Right Cessation
- 2002-04-15 HR HR20020330A patent/HRP20020330A2/en not_active IP Right Cessation
- 2002-04-18 ZA ZA200203102A patent/ZA200203102B/en unknown
- 2002-04-19 NO NO20021859A patent/NO323409B1/en not_active IP Right Cessation
-
2003
- 2003-04-16 HK HK03102754A patent/HK1050535A1/en not_active IP Right Cessation
-
2012
- 2012-02-01 CY CY20121100113T patent/CY1112274T1/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20021859L (en) | New oligosaccharides, their preparation and pharmaceutical preparations containing the oligosaccharides | |
NO20026064D0 (en) | New connections | |
NO20030381L (en) | Bicyclopyrazoles which are active as kinase inhibitors, processes for their preparation and pharmaceutical preparations containing such compounds | |
NO20024177D0 (en) | Pharmaceutical preparations containing azetidine derivatives, the novel derivatives and their preparation | |
PT1140993E (en) | GLYCOPEPTIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
DE60204452D1 (en) | [1,5] pyridine derivatives | |
DK0813525T3 (en) | Benzamidine derivatives, their preparation and use as anticoagulants | |
SE9901875D0 (en) | Novel compounds | |
ATE316083T1 (en) | ADAMANTANDE DERIVATIVES | |
PL337499A1 (en) | Novel 2-(iminomethyl)aminophenylic derivatives, their production and application as drugs and pharmaceutic agents containing such derivatives | |
AU2002239348A1 (en) | Pyrazolopyridine derivatives | |
NO883229L (en) | NEW BENZIMIDAZOLD DERIVATIVES, PROCEDURES FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATION CONTAINING SUCH DERIVATIVES. | |
NO971625L (en) | Novel peptides with immunomodulatory effects | |
DK1194415T3 (en) | New piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing them and a process for their preparation | |
BR9813719A (en) | Therapeutic agents | |
YU72802A (en) | Pharmaceutical compositions containing oligosaccharides and preparation thereof | |
ATE274515T1 (en) | PYRAZOLOPYRIDINE DERIVATIVES | |
SE9904128D0 (en) | Novel compounds | |
DE60222465D1 (en) | PYRAZOLOPYRIDINE DERIVATIVES AS ANTI-HERPING AGENTS | |
ES2192789T3 (en) | HYDRAZON-BENZAZULEN DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND INTERMEDIATE COMPOUNDS. | |
NO991589L (en) | Novel 3-, 5- and / or 6-substituted analogues of swainsonine, methods for their preparation and their use as therapeutic agents | |
NO20000424D0 (en) | Streptogramins, their preparation and preparations containing the compounds | |
SE9803107D0 (en) | Novel Compunds | |
NO20020914D0 (en) | Alkoxy-substituted benzimidazole compounds, preparations containing them and their applications | |
DK1104419T3 (en) | N-substituted azabicyloheptane derivatives, their preparation and use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |